Skip to main content
Premium Trial:

Request an Annual Quote

James Mock

PerkinElmer has appointed James Mock as senior vice president and CFO, effective May 1. Mock will replace Andy Wilson as CFO. Wilson, who previously announced his retirement from PerkinElmer, will remain with the company as an advisor for an interim period to ensure a smooth integration, the firm said. Mock has served for nearly 20 years in a wide range of financial oversight capacities within General Electric, most recently as vice president of GE's corporate audit staff, where he worked on controllership reviews and operational excellence projects. 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.